Recent Articles from GlobeNewswire
Nantong Bureau of Commerce
By Nantong Bureau of Commerce · Via GlobeNewswire · December 8, 2025
London, United Kingdom, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Daedalus Special Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Co-Chief Executive Officers Husnu Akin Babayigit and Orkun Kilic, today announced the upsized pricing of its initial public offering of 22,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Global Market tier of the Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “DSACU” beginning December 9, 2025. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “DSAC” and “DSACW,” respectively.
By Daedalus Special Acquisition Corp. · Via GlobeNewswire · December 8, 2025
BEIJING, Dec. 08, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that three studies of its novel BCL2 inhibitor, Mesutoclax (ICP-248), were presented at the 67th Annual Meeting of the American Society of Hematology (ASH). Mesutoclax demonstrated remarkable efficacy and a favorable safety profile in the treatment of relapsed/refractory (R/R) mantle cell lymphoma (MCL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), and acute myeloid leukemia (AML).
By InnoCare Pharma · Via GlobeNewswire · December 8, 2025
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against ALT5 Sigma Corp (“ALT5” or the “Company”) (NASDAQ:ALTS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
By Kirby McInerney LLP · Via GlobeNewswire · December 8, 2025
Zwerling expected to guide the Company to its commercial launch
By RetinalGeniX Technologies, Inc. · Via GlobeNewswire · December 8, 2025
Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemias
By Bioheng Therapeutics · Via GlobeNewswire · December 8, 2025
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DexCom, Inc. (NASDAQ:DXCM) and CarMax, Inc. (NYSE:KMX). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · December 8, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fiserv (FI) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · December 8, 2025
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 8, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Synopsys To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · December 8, 2025
Two oral presentations showcase robust efficacy and durable responses
By Bioheng Therapeutics · Via GlobeNewswire · December 8, 2025
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced the closing of its offering of convertible senior notes and repurchase of certain existing convertible notes.
By IREN · Via GlobeNewswire · December 8, 2025
BURNABY, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today that it has made several leadership changes. Mike Mackay has been appointed Executive Vice President & Chief Financial Officer, effective December 8, 2025. Mr. Mackay, who joined Interfor in 2015, has held several leadership roles in the Company’s finance organization, most recently serving as Vice President, Corporate Development & Treasury. Mr. Mackay will succeed Rick Pozzebon, who will be leaving Interfor to pursue other opportunities.
By Interfor Corporation · Via GlobeNewswire · December 8, 2025
MEXICO CITY, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) reports its November 2025 operational results:
By Grupo Aeroméxico, S.A.B. de C.V. · Via GlobeNewswire · December 8, 2025
FORT WASHINGTON, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL) (TollBrothers.com), the nation’s leading builder of luxury homes, today announced results for its fourth quarter ended October 31, 2025.
By Toll Brothers, Inc. · Via GlobeNewswire · December 8, 2025
LONG BEACH, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced the Neutron launch vehicle’s innovative “Hungry Hippo” captive fairing has successfully completed qualification testing and is enroute to Virginia for Neutron’s first launch.
By Rocket Lab Corporation · Via GlobeNewswire · December 8, 2025
TULSA, Okla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- ONEOK, Inc. (NYSE: OKE) will participate in an investor conference this week and in a fireside chat session at 2:15 p.m. Eastern Time (1:15 p.m. Central Time) on Tuesday, Dec. 9.
By ONEOK · Via GlobeNewswire · December 8, 2025
LATHAM, N.Y., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, appoints Sean Gadd as the company’s new President and Chief Executive Officer as part of a CEO transition that will take effect on January 5, 2026. The appointment follows a comprehensive search as part of a succession planning process led by the Board and current CEO Scott Rajeski, who will be retiring from Latham and will serve as a special advisor to the company.
By Latham Pool Products · Via GlobeNewswire · December 8, 2025
HOUSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today announced that Orion management will participate in the Roth Capital Partners 14th Annual Deer Valley Event. Management will participate in one-on-one meetings on Thursday, December 11, 2025.
By Orion Group Holdings, Inc. · Via GlobeNewswire · December 8, 2025
New Comscore analysis measures and analyzes AI usage, surfacing how the adoption of AI is changing the ways that consumers search, discover, and purchase
By Comscore, Inc. · Via GlobeNewswire · December 8, 2025
WINNEMUCCA, Nev., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announces today that The Oregon Department of Geology and Mineral Industries (“DOGAMI”) has published the draft consolidated permit package for the Grassy Mountain Gold Project on behalf of all state permitting and cooperating agencies.
By Paramount Gold Nevada Corp. · Via GlobeNewswire · December 8, 2025
LONDON and GAITHERSBURG, Md., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces presentation of preliminary data from the ongoing Phase 1 CARLYSLE trial in patients with severe refractory systemic lupus erythematosus (srSLE) in an oral presentation at the American Society of Hematology (ASH) Annual Meeting.
By Autolus Therapeutics plc · Via GlobeNewswire · December 8, 2025
– 98% reduction in HSV-2 shedding rate, >99% reduction in high viral load shedding rate and 91% reduction in virologically confirmed genital lesion rate observed in 50 mg weekly oral dose of ABI-1179, exceeding expectations for the study –
By Assembly Biosciences, Inc. · Via GlobeNewswire · December 8, 2025
NORWALK, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NYSE American: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced the closing of its previously announced underwritten public offering of 2,500,000 shares of its common stock and warrants to purchase 2,500,000 shares of common stock (collectively, the “Securities”). Each share of common stock and accompanying warrant to purchase one share of common stock were sold together at a combined public offering price of $4.00. The warrants have an exercise price of $4.50 per share, are exercisable immediately and will expire five years from the issuance date. In addition, Reed’s granted the underwriters a 45-day option to purchase up to an additional 375,000 shares of common stock and/or 375,000 warrants at their respective public offering prices, less underwriting discounts and commissions.
By Reeds, Inc. · Via GlobeNewswire · December 8, 2025
WALTHAM, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has commenced an underwritten public offering of $300,000,000 of shares of its common stock. Dyne also intends to grant the underwriters a 30-day option to purchase up to an additional $45,000,000 of shares of its common stock. All of the shares in the proposed offering are to be sold by Dyne.
By Dyne Therapeutics, Inc. · Via GlobeNewswire · December 8, 2025
CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that it has commenced an underwritten public offering of $150.0 million of shares of its common stock. Fulcrum also intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock offered in the proposed public offering. All of the shares in the proposed offering are to be sold by Fulcrum.
By Fulcrum Therapeutics, Inc. · Via GlobeNewswire · December 8, 2025
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced the commencement of a proposed underwritten public offering, subject to market and other conditions, to issue and sell $500 million of American depositary shares (ADSs), each representing three ordinary shares, or for certain investors that so choose, in lieu of ADSs, pre-funded warrants to purchase ordinary shares, represented by ADSs. All securities are being offered by Structure Therapeutics.
By Structure Therapeutics Inc. · Via GlobeNewswire · December 8, 2025
BRISBANE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced its plans to commence a public offering, subject to market and other conditions, to issue and sell $200.0 million of shares of its Class A common stock. All of the shares are being offered by Vera Therapeutics.
By Vera Therapeutics · Via GlobeNewswire · December 8, 2025
INDIANAPOLIS, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG), a premier owner and operator of high-quality, open-air grocery-anchored centers and vibrant mixed-use assets, today announced that the Company closed on the disposition of a portfolio that includes eight large-format power and community centers for gross proceeds of $429.0 million.
By Kite Realty Group Trust · Via GlobeNewswire · December 8, 2025
CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”), announced today that it has commenced an underwritten public offering of $250 million in aggregate of its ordinary shares, and, to certain investors that so choose in lieu of ordinary shares, pre-funded warrants to purchase ordinary shares. In connection with the offering, Wave intends to grant the underwriters a 30-day option to purchase ordinary shares in an amount up to an additional 15% of the total amount of ordinary shares and shares underlying pre-funded warrants sold in the public offering on the same terms and conditions. All of the securities in the offering will be sold by Wave Life Sciences.
By Wave Life Sciences USA, Inc. · Via GlobeNewswire · December 8, 2025
$2 million upfront with up to approximately $3.5 million of potential aggregate proceeds upon the exercise in full of warrants
By Ascent Solar Technologies, Inc. · Via GlobeNewswire · December 8, 2025
WESTLAKE VILLAGE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Amit Munshi has been appointed to the Arcutis Board of Directors effective December 4, 2025, and announced the retirement of founder and long-serving Board member Bhaskar Chaudhuri, PhD. Dr. Chaudhuri will continue as a consultant for the Company.
By Arcutis Biotherapeutics, Inc. · Via GlobeNewswire · December 8, 2025
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 8, 2025
Company invites individual and institutional investors, financial advisors, and analysts to attend online via VirtualInvestorConferences.com
By Virtual Investor Conferences; Xtreme One Entertainment, Inc. · Via GlobeNewswire · December 8, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences; DarkPulse, Inc. · Via GlobeNewswire · December 8, 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
By Halper Sadeh LLC · Via GlobeNewswire · December 8, 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
By Halper Sadeh LLC · Via GlobeNewswire · December 8, 2025
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Company: Fiserv, Inc. (NASDAQ: FI) is a Milwaukee, Wisconsin-based global payments and financial technology provider.
By Robbins LLP · Via GlobeNewswire · December 8, 2025
McLEAN, Va., Dec. 08, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Mission Technologies division has deployed and operationalized a next-generation high-performance spectrum dominance solution, now available for rapid detection and location of hostile communications, radar and other electronic threats.
By HII · Via GlobeNewswire · December 8, 2025
Available properties include 83 owned and leased sites across 38 states
By Gordon Brothers · Via GlobeNewswire · December 8, 2025
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · December 8, 2025
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 8, 2025
OPESS AI combines innovation and convenience in a daily rewards plan, enabling users to make profits worry-free, anytime
By OPESS AI · Via GlobeNewswire · December 8, 2025
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.
By USA News Group · Via GlobeNewswire · December 8, 2025
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · December 8, 2025
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · December 8, 2025
By Bombardier Inc. · Via GlobeNewswire · December 8, 2025
Y-USA Partnered with The Martin Agency to Develop Nationwide Customizable Campaign
By YMCA of the USA · Via GlobeNewswire · December 8, 2025
Appointment brings HOA expertise and on-the-ground housing insights to New Jersey’s policy priorities
By Community Associations Institute · Via GlobeNewswire · December 8, 2025
Despite industry-wide pressures leading to credit downgrades outpacing upgrades, S&P’s positive revision cites Ballad Health’s experienced management team, execution of integration strategy, and quality improvement serving to “transform Ballad Health into a high-performing consolidated system”
By Ballad Health · Via GlobeNewswire · December 8, 2025
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Asymmetric Research, a specialized security firm focused on long-term partnerships with L1s, L2s, and DeFi teams, and OtterSec, a technical audit company known for uncovering complex vulnerabilities, have formalized a shared leadership model that brings together two of the most technical teams in blockchain and web3 security. This move aligns leadership while preserving each team’s existing focus and operational track.
By Asymmetric Research · Via GlobeNewswire · December 8, 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
By Halper Sadeh LLC · Via GlobeNewswire · December 8, 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
By Halper Sadeh LLC · Via GlobeNewswire · December 8, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences; Amplia Therapeutics · Via GlobeNewswire · December 8, 2025
The national America’s Cutting Edge (ACE) program has helped manufacturing workers, students, teachers, and more gain in-demand skills to revitalize domestic manufacturing.
By IACMI - The Composites Institute · Via GlobeNewswire · December 8, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences; Echo IQ · Via GlobeNewswire · December 8, 2025
Transaction in Own Shares
By Shell plc · Via GlobeNewswire · December 8, 2025
Monthly declaration of the total number of shares and voting rights composing the company's capital (at November 30th, 2025)
By LECTRA · Via GlobeNewswire · December 8, 2025
Toy Trends Specialist, Jennifer Lynch, Shares This Year’s Must-Have Picks, Highlighting Screen-Free Play, Immersive Toys, and Nostalgic, Feel-Good Favorites
By D S Simon · Via GlobeNewswire · December 8, 2025
Yamaha Honors YFZ450R and YXZ1000R Racers at Annual Wall of Champions Celebration
By Yamaha Motor Corp., USA · Via GlobeNewswire · December 8, 2025
Rushil Desai joins national leaders to discuss HR1, SNAP, and rural health innovation
By Gainwell Technologies LLC · Via GlobeNewswire · December 8, 2025
First and only IL5 PHI-authorized Generative AI platform approved for clinical and operational use across DHA
By Ask Sage · Via GlobeNewswire · December 8, 2025
BALA CYNWYD, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · December 8, 2025
BALA CYNWYD, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · December 8, 2025
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).
By Lowey Dannenberg, P.C. · Via GlobeNewswire · December 8, 2025
LOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Six Flags Entertainment Corporation (“Six Flags” or “the Company”) (NYSE: FUN) for violations of the federal securities laws.
By Schall Law · Via GlobeNewswire · December 8, 2025
Applications for the 2026-27 school year are open now through Feb. 2, 2026
By D S Simon · Via GlobeNewswire · December 8, 2025
December 2025 — Global cryptocurrency exchange Zoomex has officially launched the “ZOOtopia Trading Festival,” a platform-wide event combining meme-coin trading, daily missions, and exclusive community rewards. The campaign features a total prize pool of 30,000 USDT in airdrops, along with additional perks including fee rebates and movie-ticket giveaways.
By Zoomex · Via GlobeNewswire · December 8, 2025
LOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · December 8, 2025
New evidence from a six-country study led by the Montreal Children’s Hospital and Children’s National Hospital shows simple blood and urine tests could spare many young infants with fevers from more invasive procedures.
By Children's National Hospital · Via GlobeNewswire · December 8, 2025
MAYFIELD VILLAGE, OHIO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- On December 5, 2025, the Board of Directors of The Progressive Corporation (NYSE:PGR) declared an annual common share dividend, in the amount of $13.50 per share, and a quarterly common share dividend, in the amount of $0.10 per share.
By Progressive Casualty Insurance Company · Via GlobeNewswire · December 8, 2025
The High Cost of Holiday FOMO: How Fear, Guilt, and Social Pressure Drive Debt
By D S Simon · Via GlobeNewswire · December 8, 2025
LOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · December 8, 2025
CHANTILLY, Va., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:PSN), the systems integrator for the Office of Space Commerce’s (OSC) Traffic Coordination System for Space (TraCSS) program, is proud to announce that this groundbreaking advancement in space traffic coordination has been recognized with the esteemed 2025 SpaceNews Icon Award for Civil Space Achievement. This prestigious accolade underscores Parsons' commitment to advancing safe and efficient operations in an increasingly congested orbital environment.
By Parsons Services Company · Via GlobeNewswire · December 8, 2025
Palm Beach, Broward, and Miami-Dade Counties’ economic development leaders spotlight current connectivity and new cross-market opportunities between NYC and South Florida ‘Mega Region’
By Greater Fort Lauderdale Alliance · Via GlobeNewswire · December 8, 2025
